A Sämann1, I Mühlhauser, R Bender, Ch Kloos, U A Müller. 1. Department of Internal Medicine III, Friedrich Schiller University, Erlanger Allee 101, D-07740, Jena, Germany. alexander.saemann@med.uni-jena.de
Abstract
AIMS/HYPOTHESIS: The aim of this study was to evaluate the implementation of a course teaching flexible, intensive insulin therapy on glycaemic control and severe hypoglycaemia in routine care. METHODS: This is a continuous quality-assurance project involving hospital diabetes centres. Every third year each centre re-examines 50 consecutive patients (evaluation sample) 1 year after participation in the course. Ninety-six diabetes centres in Germany participated and 9,583 patients with type 1 diabetes (190 evaluation samples) were re-examined between 1992 and 2004. The intervention was a 5-day inpatient course for groups of up to ten patients with a fixed curriculum of education and training for dietary flexibility and insulin adjustment. The main outcome measures were HbA1c and severe hypoglycaemia. RESULTS: Mean baseline HbA1c was 8.1%, and had decreased to 7.3% at follow-up; incidence of severe hypoglycaemia was 0.37 events per patient per year prior to intervention and 0.14 after intervention. In mixed-effects models adjusted for effects of centres, age and diabetes duration, the mean difference was -0.7% (95% CI -0.9 to -0.6%, p<0.0001) for HbA1c and -0.21 events per patient per year (95% CI -0.32 to -0.11, p=0.0001) for severe hypoglycaemia, with similar results for evaluation samples, with a maximum of 10% of patients lost to follow-up. Before intervention, the incidence of severe hypoglycaemia was three-fold higher in the lowest quartile than in the highest quartile of HbA1c, whereas the risk was comparable across the range of HbA1c values after intervention. CONCLUSIONS/ INTERPRETATION: Implemented as part of a continuous quality-assurance programme the self-management programme is effective and safe in routine care. Improvement of glycaemic control can be achieved without increasing the risk of severe hypoglycaemia.
AIMS/HYPOTHESIS: The aim of this study was to evaluate the implementation of a course teaching flexible, intensive insulin therapy on glycaemic control and severe hypoglycaemia in routine care. METHODS: This is a continuous quality-assurance project involving hospital diabetes centres. Every third year each centre re-examines 50 consecutive patients (evaluation sample) 1 year after participation in the course. Ninety-six diabetes centres in Germany participated and 9,583 patients with type 1 diabetes (190 evaluation samples) were re-examined between 1992 and 2004. The intervention was a 5-day inpatient course for groups of up to ten patients with a fixed curriculum of education and training for dietary flexibility and insulin adjustment. The main outcome measures were HbA1c and severe hypoglycaemia. RESULTS: Mean baseline HbA1c was 8.1%, and had decreased to 7.3% at follow-up; incidence of severe hypoglycaemia was 0.37 events per patient per year prior to intervention and 0.14 after intervention. In mixed-effects models adjusted for effects of centres, age and diabetes duration, the mean difference was -0.7% (95% CI -0.9 to -0.6%, p<0.0001) for HbA1c and -0.21 events per patient per year (95% CI -0.32 to -0.11, p=0.0001) for severe hypoglycaemia, with similar results for evaluation samples, with a maximum of 10% of patients lost to follow-up. Before intervention, the incidence of severe hypoglycaemia was three-fold higher in the lowest quartile than in the highest quartile of HbA1c, whereas the risk was comparable across the range of HbA1c values after intervention. CONCLUSIONS/ INTERPRETATION: Implemented as part of a continuous quality-assurance programme the self-management programme is effective and safe in routine care. Improvement of glycaemic control can be achieved without increasing the risk of severe hypoglycaemia.
Authors: E G Starostina; M Antsiferov; G R Galstyan; C Trautner; V Jörgens; U Bott; I Mühlhauser; M Berger; I I Dedov Journal: Diabetologia Date: 1994-02 Impact factor: 10.122
Authors: J Plank; G Köhler; I Rakovac; B M Semlitsch; K Horvath; G Bock; B Kraly; T R Pieber Journal: Diabetologia Date: 2004-07-17 Impact factor: 10.122
Authors: I Mühlhauser; V Jörgens; M Berger; W Graninger; W Gürtler; L Hornke; A Kunz; G Schernthaner; V Scholz; H E Voss Journal: Diabetologia Date: 1983-12 Impact factor: 10.122
Authors: I Mühlhauser; I Bruckner; M Berger; D Cheţa; V Jörgens; C Ionescu-Tîrgovişte; V Scholz; I Mincu Journal: Diabetologia Date: 1987-09 Impact factor: 10.122
Authors: Seán F Dinneen; Mary Clare O' Hara; Molly Byrne; John Newell; Lisa Daly; Donal O' Shea; Diarmuid Smith Journal: Trials Date: 2009-09-23 Impact factor: 2.279
Authors: J T George; A P Valdovinos; I Russell; P Dromgoole; S Lomax; D J Torgerson; T Wells; J C Thow Journal: Diabet Med Date: 2008-12 Impact factor: 4.359